Systematic review / meta-analysis / 2013
Oily fish consumption was linked to a lower risk of type 2 diabetes, though total fish/seafood and marine omega-3 fatty acids showed no significant link.
A systematic review and meta-analysis evaluated prospective cohort studies examining fish/seafood and marine long-chain omega-3 PUFA intake and type 2 diabetes (T2D) risk. There was no significant association between T2D risk and total fish/seafood (pooled RR: 1.04; 95% CI: 0.9 to 1.2; P = 0.63; 549,955 participants) or marine LC n-3 PUFAs (pooled RR: 1.08; 95% CI: 0.90 to 1.30; P = 0.39; 346,710 participants). However, oily fish intake was associated with a reduced risk of T2D (pooled RR: 0.89; 95% CI: 0.82 to 0.96; P = 0.005), with dose-response analysis suggesting an 80 g/day intake may reduce risk by 20%. Significant study heterogeneity was observed for fish/seafood and marine LC n-3 PUFA studies.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of prospective cohort studies
- Who was studied
- Up to 549,955 participants across prospective cohort studies
- What was measured
- Incidence of type 2 diabetes
THE PAPER
Fish and marine omega-3 polyunsatured Fatty Acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis.
Zhang M, Picard-Deland E, Marette A. Int J Endocrinol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.